Troy Healthcare launches Stopain Clinical Migraine & Headache, formulated without acetaminophen, aspirin, caffeine or other NSAIDs as a pain-relief alternative to potentially addictive opioids.

The launch of the product comes at a time when frequency of migraines is estimated to be on the rise due to increased stress from pandemic-related economic hardships and COVID-19-associated headaches.

Troy Healthcare provides Stopain Clinical, a topical analgesic offered by physical therapists and others to help those suffering from arthritis, chronic pain, back aches or sprains. The active ingredients in Stopain Clinical Migraine & Headache are formulated to help reduce the symptoms typically associated with migraines, including pain in the front and back of the head, as well as help control nausea and sickness.

“With consumers becoming more aware of the negative long-term effects of the ingestible medication they’re using, we’re proud to offer a topical solution that is safe and effective in relieving migraines and headaches during any stage of progression. Being able to use this product multiple times per day and in conjunction with other pain-relieving products has been a huge benefit for migraine and severe headache sufferers.”

— Anthony Cicini, President of Troy Healthcare LLC

A study conducted at Thomas Jefferson Headache Center suggests a significant improvement in headache intensity within two hours of application. The study further suggests that after 2 hours, 52% of participants saw significant improvement by at least one severity level and 32% had no additional pain progression.

Director at the Jefferson Headache Center, Dr. Stephen Silberstein, determined in his conclusion statement that the product “is safe and effective in the treatment of an acute migraine attack.” (Thomas Jefferson Headache Center, 2012)

Stopain Clinical Migraine & Headache is sold exclusively through healthcare professionals. For more information and to find a healthcare facility offering Stopain Clinical Migraine & Headache, visit Stopain.

[Source(s): Troy Healthcare LLC, PRWeb]

Related Content:
Peptide Common in Migraine and Opioid Overuse May be the Link to Pain Treatment
Facial Pain Can Be a Symptom of Headaches, Too
gammaCore Cluster Headache Device Receives FDA Nod